Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SurModics Inc (NASDAQ:SRDX)

22.49
Delayed Data
As of May 27
 -0.15 / -0.66%
Today’s Change
17.45
Today|||52-Week Range
27.68
+10.95%
Year-to-Date
IDEXX Laboratories: Strong Instrument Placement Drives Q1
8:49am / Zacks.com - Paid Partner Content
Quality Systems (QSII) Q4 Earnings Disappoint, Stock Falls
May 20 / Zacks.com - Paid Partner Content
Cepheid: GeneXpert Placements High, Currency Woes Stay
May 27 / Zacks.com - Paid Partner Content
Boston Scientific's Full-Body MRI SCS System Gets FDA Nod
May 20 / Zacks.com - Paid Partner Content
Qiagen, Therawis Diagnostics to Develop Breast Cancer Test
May 27 / Zacks.com - Paid Partner Content
Bristol-Myers' Opdivo Wins FDA Nod for Additional Indication
May 18 / Zacks.com - Paid Partner Content
ResMed: Positive CAT-HF Study Results to Drive ASV Sales
May 25 / Zacks.com - Paid Partner Content
Edwards Lifesciences Presents Positive Data on Sapien3
May 18 / Zacks.com - Paid Partner Content
Edwards Lifesciences: Q1 Strong, TAVR Prospects Bright
May 25 / Zacks.com - Paid Partner Content
Bruker: Q1 Results Strong, Product Launches Hold Promise
May 17 / Zacks.com - Paid Partner Content
Baxter Unveils THERANOVA Dialyser at ERA-EDTA Congress
May 25 / Zacks.com - Paid Partner Content
Myriad Genetics Brings myVectra Web Portal for RA Patients
May 17 / Zacks.com - Paid Partner Content
Baxter (BAX) Raised to Strong Buy on Estimate Revisions
May 20 / Zacks.com - Paid Partner Content